PATH, Coalition for Access to NCD Medicines and Products
The case for financing action on noncommunicable diseases – even, and especially, in times of crisis
Briefs & Fact Sheets
28 May 2025
The availability, cost and affordability of essential medicines for asthma and COPD in LMIC: a systematic review, Lancet Global Health 2022
01 Oct 2022
This systematic review, commissioned by WHO, explored the availability, cost and affordability of essential medicines for asthma and COPD in LMICs in published literature between 2010-2022. Inhaled medicines were largely unavailable and unaffordable – this was particularly true for inhalers containing corticosteroids.
